Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05557903
What this trial is testing

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, T-Cell
Lanzhou Institute of Biological Products Co., Ltd 71
Early research (Phase 1)Ended earlyNCT04803227
What this trial is testing

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Who this might be right for
Covid19
Histogen 13
Testing effectiveness (Phase 2)Study completedNCT01611259
What this trial is testing

Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue

Who this might be right for
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Arbeitsgemeinschaft medikamentoese Tumortherapie 50
Early research (Phase 1)Study completedNCT00005580
What this trial is testing

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880
What this trial is testing

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01579461
What this trial is testing

Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects

Who this might be right for
PharmacokineticsHealthy SubjectsMild and Moderate Hepatic Impairment
Astellas Pharma Europe B.V. 32
Testing effectiveness (Phase 2)Study completedNCT01448096
What this trial is testing

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse Lymphoma
Chonbuk National University Hospital 33
Large-scale testing (Phase 3)Not Yet RecruitingNCT07712588
What this trial is testing

Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Dizal Pharmaceuticals 880
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Ended earlyNCT00529503
What this trial is testing

Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Seagen Inc. 151
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02205333
What this trial is testing

A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies

Who this might be right for
Advanced Solid TumorsAggressive B-cell Lymphomas
MedImmune LLC 48
Testing effectiveness (Phase 2)Study completedNCT00069238
What this trial is testing

Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas

Who this might be right for
Lymphoma, T-CellLymphoma, Extranodal NK-T-Cell
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Ended earlyNCT05490043
What this trial is testing

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorMature B-cell Non-Hodgkin Lymphoma
Antengene (Hangzhou) Biologics Co., Ltd. 33
Testing effectiveness (Phase 2)Looking for participantsNCT06471738
What this trial is testing

Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaGrade 1 Follicular LymphomaAnn Arbor Stage III Follicular Lymphoma+3 more
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06375733
What this trial is testing

GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL

Who this might be right for
Large B-cell Lymphoma
Genfleet Therapeutics (Shanghai) Inc. 51
Not applicableLooking for participantsNCT06584448
What this trial is testing

Drinking, Acetate, and Stress

Who this might be right for
Alcohol Use DisorderAlcohol Use, UnspecifiedHeavy Drinker+1 more
Yale University 50
Next Page